InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 246739

Saturday, 12/26/2015 1:50:09 AM

Saturday, December 26, 2015 1:50:09 AM

Post# of 346054
I agree and the time is finally coming down that big things seem awfully close to being announced. CXCR2 out of MD Anderson research seems like they are trying everything in their power not to mention PS Targeting.

Bavi combo trials seem like they must not be delayed with all this competition out there

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News